These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9478933)

  • 1. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases.
    Shi ZQ; Lu W; Feng GS
    J Biol Chem; 1998 Feb; 273(9):4904-8. PubMed ID: 9478933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.
    Deb TB; Wong L; Salomon DS; Zhou G; Dixon JE; Gutkind JS; Thompson SA; Johnson GR
    J Biol Chem; 1998 Jul; 273(27):16643-6. PubMed ID: 9642214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for protein-tyrosine phosphatase SHP-2 in insulin-induced activation of c-Jun NH(2)-terminal kinase.
    Fukunaga K; Noguchi T; Takeda H; Matozaki T; Hayashi Y; Itoh H; Kasuga M
    J Biol Chem; 2000 Feb; 275(7):5208-13. PubMed ID: 10671568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals.
    Qu CK; Yu WM; Azzarelli B; Feng GS
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8528-33. PubMed ID: 10411909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
    Frearson JA; Alexander DR
    J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
    Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
    EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells.
    You M; Zhao Z
    J Biol Chem; 1997 Sep; 272(37):23376-81. PubMed ID: 9287352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.
    Qu CK; Shi ZQ; Shen R; Tsai FY; Orkin SH; Feng GS
    Mol Cell Biol; 1997 Sep; 17(9):5499-507. PubMed ID: 9271425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts.
    Kontaridis MI; Liu X; Zhang L; Bennett AM
    Mol Cell Biol; 2002 Jun; 22(11):3875-91. PubMed ID: 11997521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
    Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
    J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor.
    You M; Flick LM; Yu D; Feng GS
    J Exp Med; 2001 Jan; 193(1):101-10. PubMed ID: 11136824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.
    Geng Y; Valbracht J; Lotz M
    J Clin Invest; 1996 Nov; 98(10):2425-30. PubMed ID: 8941662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
    Tang H; Zhao ZJ; Landon EJ; Inagami T
    J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling.
    Zhao R; Zhao ZJ
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):35-9. PubMed ID: 9931295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity.
    Shi ZQ; Yu DH; Park M; Marshall M; Feng GS
    Mol Cell Biol; 2000 Mar; 20(5):1526-36. PubMed ID: 10669730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.